Assessment of Key Factors Impacting Variability in AAV Vector Genome Titration by Digital PCR
Open Access
- 9 May 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (10) , 5149
Abstract
Recombinant adeno-associated virus (rAAV) has emerged as a prominent vector for in vivo gene therapy, owing to its distinct advantages. Accurate determination of the rAAV genome titer is crucial for ensuring the safe and effective administration of clinical doses. The evolution of the rAAV genome titer assay from quantitative PCR (qPCR) to digital PCR (dPCR) has enhanced accuracy and precision, yet practical challenges persist. This study systematically investigated the impact of various operational factors on genome titration in a single-factor manner, aiming to address potential sources of variability in the quantitative determination process. Our findings revealed that a pretreatment procedure without genome extraction exhibits superior precision compared with titration with genome extraction. Additionally, notable variations in titration results across different brands of dPCR instruments were documented, with relative standard deviation (RSD) reaching 23.47% for AAV5 and 11.57% for AAV8. Notably, optimal operations about DNase I digestion were identified; we thought treatment time exceeding 30 min was necessary, and there was no need for thermal inactivation after digestion. And we highlighted that thermal capsid disruption before serial dilution substantially affected AAV genome titers, causing a greater than ten-fold decrease. Conversely, this study found that additive components of dilution buffer are not significant contributors to titration variations. Furthermore, we found that repeated freeze–thaw cycles significantly compromised AAV genome titers. In conclusion, a comprehensive dPCR titration protocol, incorporating insights from these impact factors, was proposed and successfully tested across multiple serotypes of AAV. The results demonstrate acceptable variations, with the RSD consistently below 5.00% for all tested AAV samples. This study provides valuable insights to reduce variability and improve the reproducibility of AAV genome titration using dPCR.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFC3403305)
This publication has 14 references indexed in Scilit:
- Unveiling the secrets of adeno-associated virus: novel high-throughput approaches for the quantification of multiple serotypesMolecular Therapy - Methods & Clinical Development, 2023
- Insight and Development of Advanced Recombinant Adeno-Associated Virus Analysis Tools Exploiting Single-Particle Quantification by Multidimensional Droplet Digital PCRHuman Gene Therapy, 2022
- Current commercial dPCR platforms: technology and market reviewCritical Reviews in Biotechnology, 2022
- Optimized Protocol for Accurate Titration of Adeno-Associated Virus VectorsHuman Gene Therapy, 2021
- Viral vector platforms within the gene therapy landscapeSignal Transduction and Targeted Therapy, 2021
- A qPCR Method for AAV Genome Titer with ddPCR-Level of Accuracy and PrecisionMolecular Therapy - Methods & Clinical Development, 2020
- Quantitative and Digital Droplet-Based AAV Genome Titration2019
- Adeno-associated virus vector as a platform for gene therapy deliveryNature Reviews Drug Discovery, 2019
- Thermal Stability as a Determinant of AAV Serotype IdentityMolecular Therapy - Methods & Clinical Development, 2017
- Absolute Determination of Single-Stranded and Self-Complementary Adeno-Associated Viral Vector Genome Titers by Droplet Digital PCRHuman Gene Therapy Methods, 2014